Haemonetics
207 hedge funds and large institutions have $2.46B invested in Haemonetics in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 77 increasing their positions, 72 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.52% less ownership
Funds ownership: 105.66% → 104.14% (-1.5%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
207
Holding in Top 10
2
Calls
$4K
Puts
–
Top Buyers
| 1 | +$17.1M | |
| 2 | +$11.2M | |
| 3 | +$9.01M | |
| 4 |
BlackRock
New York
|
+$8.53M |
| 5 |
Neuberger Berman Group
New York
|
+$8.52M |
Top Sellers
| 1 | -$35.2M | |
| 2 | -$28.1M | |
| 3 | -$18.1M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$17.5M |
| 5 |
Morgan Stanley
New York
|
-$9.9M |